Compound 329
Identifiers
- Canonical SMILES:
Fc1cccc(c1)-n1[nH]c2c3cnn(-c4ccccc4)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C26H15F4N5O/c27-17-8-5-11-19(13-17)35-25(36)21-22(15-6-4-7-16(12-15)26(28,29)30)32-24-20(23(21)33-35)14-31-34(24)18-9-2-1-3-10-18/h1-14,33H
- InChiKey:
KSWTXHZSEYXKAY-UHFFFAOYSA-N
External links
168318234 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.12 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 489.12 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 6.79 | |||
TPSA | 63.05 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5190 | Riociguat | DB08931 | |
0.5020 | Vericiguat | DB15456 | |
0.4934 | ATX-914 | DB12673 | |
0.4786 | Tepotinib | DB15133 | |
0.4744 | MK-0249 | DB11910 | |
0.4694 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4619 | Dilmapimod | DB12140 | |
0.4550 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4541 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4504 | Risdiplam | DB15305 | |
0.4449 | Ravoxertinib | DB15281 | |
0.4402 | Merestinib | DB12381 | |
0.4392 | Methaqualone | DB04833 | |
0.4340 | CVT-6883 | DB05936 | |
0.4322 | Rilematovir | DB15672 |